Startup Deep Dive : Endimension — Raised Rs 6 crore in a pre-Series A round led by Inflection Point Ventures in April 2024; platform claimed in 400 hospitals

Endimension Technology Private Limited is a Mumbai-based Indian healthcare AI startup, incubated at IIT Bombay, that builds an AI platform to help radiologists detect abnormalities in medical scans.

This Startup Deep Dive explains what Endimension does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Endimension in Brief

  • What it is: Endimension is an Indian Healthcare AI, radiology company based in Mumbai.
  • Who it serves: businesses, institutions, consumers, learners and public-sector buyers.
  • Builds an end-to-end AI platform for radiology diagnostics aimed at improving radiologist efficiency, accuracy and detection rates.
  • Uses AI to automatically detect abnormalities and diseases in scans, and generative AI to streamline report generation.
  • Says its platform is deployed in 400 hospitals and diagnostic centres and has processed over 1 million scans (company claims).
  • Funding: About Rs 8.3 crore across two disclosed rounds (Rs 2.3 crore seed and Rs 6 crore pre-Series A); an aggregator lists about $1.03 million.

Endimension Quick Facts

Company Endimension
Founded 2018
Headquarters Mumbai
Founders Bharadwaj Kss, Apparao M L V
Sector Healthcare AI, radiology
Total funding About Rs 8.3 crore across two disclosed rounds (Rs 2.3 crore seed and Rs 6 crore pre-Series A); an aggregator lists about $1.03 million
Latest round Pre-Series A, Rs 6 crore, April 2024, led by Inflection Point Ventures
Valuation Not disclosed
Website Not disclosed

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Endimension?

Endimension operates in the Healthcare AI, radiology space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Endimension.

  • Builds an end-to-end AI platform for radiology diagnostics aimed at improving radiologist efficiency, accuracy and detection rates.
  • Uses AI to automatically detect abnormalities and diseases in scans, and generative AI to streamline report generation.
  • Says its platform is deployed in 400 hospitals and diagnostic centres and has processed over 1 million scans (company claims).
  • Teleradiology use cases include institutions in the West and remote areas of India.

The Origin Story of Endimension

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

  • Founders: Bharadwaj Kss, Apparao M L V.
  • Founded by Bharadwaj Kss (IIT Madras bachelor's, IIT Bombay master's) with Apparao M L V as co-founder and COO; Karthik Kannegondla is CTO.
  • Incubated at IIT Bombay.
  • Founding year reports differ: 2018 in most profiles, December 2017 in one.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Healthcare AI, radiology sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

  • September 2021: Raised Rs 2.3 crore seed round led by Inflection Point Ventures.
  • December 2023: Non-equity assistance involving Google listed by an aggregator (amount undisclosed).
  • April 2024: Raised Rs 6 crore pre-Series A led by Inflection Point Ventures with Sucseed Indovation, SINE IIT Bombay and angels.

Endimension Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

  • September 2021: Rs 2.3 crore (about $0.3 million) seed, led by Inflection Point Ventures.
  • April 2024: Rs 6 crore pre-Series A, led by Inflection Point Ventures; other investors Sucseed Indovation, SINE IIT Bombay and individual angels.

How Does Endimension Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to businesses, institutions, consumers, learners and public-sector buyers, sales cycles and contract size matter as much as headline growth.

  • Sells AI radiology software to hospitals and diagnostic centres; pricing model not stated in sources read.
  • Funds are to be used for AI research, team expansion and software enhancement.

The Numbers: Endimension Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

  • Revenue and profit not disclosed in sources read.

Market Opportunity for Endimension

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising digital adoption, cloud and mobile penetration, growing enterprise technology spending, government digitisation programmes and a deep pool of engineering talent. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

  • Targets radiology workloads at hospitals and diagnostic chains in India and teleradiology in the West.

Technology and Product at Endimension

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are product quality, data and integration depth, security, scalability and the speed of shipping improvements.

  • AI and machine learning for scan analysis, with generative AI for report drafting.
  • In-house AI team with combined 35+ years of experience (company claim).

Team and Culture at Endimension

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

  • Bharadwaj Kss: founder and CEO, about 10 years in AI and machine learning.
  • Apparao M L V: co-founder and COO.
  • Karthik Kannegondla: CTO, IIT Madras graduate.

Endimension Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Competitor How it differs
Rad AI Healthcare technology company listed as a top rival on a company-data profile.
CARPL Listed as a top rival on a company-data profile.
Blackford Analysis Listed as a top rival on a company-data profile.

Risks and Challenges for Endimension

  • Small funding base compared with global radiology AI players.
  • Regulatory approval and clinical validation requirements.
  • Hospital sales cycles are long.
  • Deployment and scan counts are company claims.
  • Competition: low barriers to entry and well-funded rivals can compress pricing and slow growth.
  • Funding risk: technology businesses often burn cash before reaching profit and depend on investor appetite.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by data protection rules under the Digital Personal Data Protection Act, sector regulators, consumer protection law and IT rules.

Endimension Growth Outlook: What to Watch

  • Fresh capital is meant to expand R&D and the sales team.
  • Generative AI for reporting is a stated product direction.
  • Key indicators: recurring revenue, customer retention, gross margin, customer acquisition cost and runway.
  • Funding position: Whether Endimension can reach its next milestone before needing new capital.
  • Regulation: Changes from data protection rules under the Digital Personal Data Protection Act, sector regulators, consumer protection law and IT rules.

Industry Context: Where Endimension Fits

India's technology startup ecosystem is one of the largest in the world, supported by cheap data, a large base of smartphone users, digital public infrastructure and a deep engineering talent pool. Companies now build for education, software, mobility, logistics, agriculture, defence, media and more, selling both to Indian customers and abroad.

Durable technology companies usually combine a clear customer problem with repeatable distribution and disciplined unit economics. Growth funded only by spending tends to fade, while products that customers keep using and paying for build compounding advantages.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Endimension

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Endimension.

Bull case

  • A large and growing base of digital users and businesses expands the addressable market.
  • Recurring revenue and strong retention can compound growth.
  • Selling into global markets widens the opportunity beyond India.

Bear case

  • Heavy competition can compress pricing and margins.
  • Dependence on external funding can force painful cost cuts.
  • Regulation or platform changes can disrupt a product quickly.

Lessons Founders and Investors Can Take from Endimension

Studying a company in the Healthcare AI, radiology space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Endimension.

  • Solving a clear, frequent customer problem matters more than adding features.
  • Retention and repeat usage are better health signals than sign-ups.
  • Disciplined spending extends runway and keeps options open when funding tightens.
  • Distribution, not just product quality, decides who wins in crowded markets.
  • Building trust through data protection and reliability is part of the product.

How to Evaluate Endimension as a Startup

  • Customer clarity: Can Endimension name its customer and the problem it solves in one sentence?
  • Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
  • Economics: Check whether margins improve as volume grows.
  • Execution: Compare announced timelines with what has actually been delivered.
  • Funding runway: Estimate how long current capital lasts at the present spending rate.
  • Regulatory standing: Confirm required approvals are in place.
  • Customer concentration: Check whether a few customers account for most of the revenue.
  • Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Endimension is part of India’s growing Healthcare AI, radiology ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. Public sources can also describe the same company in different ways, so it is worth checking dates, definitions and whether a figure refers to revenue, total income or transaction value, and whether it covers one entity or a wider group, before drawing conclusions. Small differences in rounding, currency conversion or reporting periods can also change how a figure reads. Comparing the same figure across several recent reports helps show whether it is stable or has changed over time. This article is educational and is not investment advice.

  • Clear customers and repeat demand matter more than announcements.
  • Regulation and capital needs shape how fast a startup in this sector can grow.
  • Track a few leading indicators over time rather than one headline metric.

Endimension FAQs: Frequently Asked Questions

What is Endimension?

Endimension Technology Private Limited is a Mumbai-based Indian healthcare AI startup, incubated at IIT Bombay, that builds an AI platform to help radiologists detect abnormalities in medical scans. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Endimension?

Endimension was founded by Bharadwaj Kss, Apparao M L V, and the company reports a founding year of 2018.

How much funding has Endimension raised?

About Rs 8.3 crore across two disclosed rounds (Rs 2.3 crore seed and Rs 6 crore pre-Series A); an aggregator lists about $1.03 million. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Endimension make money?

Endimension earns revenue from its Healthcare AI, radiology products and services sold to businesses, institutions, consumers, learners and public-sector buyers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Endimension?

Reported rivals include Rad AI, CARPL, Blackford Analysis. See the competitor comparison above for how they differ.

What are the main risks for Endimension?

Main risks include competition: low barriers to entry and well-funded rivals can compress pricing and slow growth, funding and capital needs, competition and regulation by data protection rules under the Digital Personal Data Protection Act, sector regulators, consumer protection law and IT rules. This is educational content, not investment advice.

Related Startup Deep Dives: Optimized Electrotech — Raised $6 million Series A led by Blume Ventures and Mela Ventures in April 2025 | Innoviti Technologies — Innoviti closed a Series E of Rs 70 Cr in equity and debt. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.

Picture of Indian Startup Times

Indian Startup Times

Leave a Reply

Your email address will not be published. Required fields are marked *